|
| 36710205 | Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial. | Eur Urol | 2024 |
| 36635202 | Association of Brachytherapy Boost with Overall Survival for Gleason 9-10 Prostate Cancer: The Impact of Primary versus Secondary Pattern 5. | Brachytherapy | 2023 |
| 38021093 | CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer. | Clin Transl Radiat Oncol | 2023 |
| 37704483 | Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder? | Clin Genitourin Cancer | 2023 |
| 37886176 | A pooled long-term follow-up after radiotherapy for prostate cancer with and without a rectal hydrogel spacer: impact of hydrogel on decline in sexual quality of life. | Front Oncol | 2023 |
| 37684069 | The Importance of Quality Assurance in Radiation Oncology Clinical Trials. | Semin Radiat Oncol | 2023 |
| 37639648 | Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate. | J Clin Oncol | 2023 |
| 37179085 | Beyond Diversity Toward Inclusion, Belonging, and Safety. | Int J Radiat Oncol Biol Phys | 2023 |
| 37236747 | ACR Appropriateness Criteria® Staging of Renal Cell Carcinoma: 2022 Update. | J Am Coll Radiol | 2023 |
| 37104748 | Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial. | J Clin Oncol | 2023 |
| 37104723 | Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized Trial. | J Clin Oncol | 2023 |
| 37137444 | Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial. | Int J Radiat Oncol Biol Phys | 2023 |
| 36592721 | Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2023 |
| 36522277 | Consensus Quality Measures and Dose Constraints for Prostate Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel. | Pract Radiat Oncol | 2023 |
| 36922080 | Radiation Oncology and Radiopharmaceuticals: Making Our Own History While Learning From the Past. | Int J Radiat Oncol Biol Phys | 2023 |
| 36846439 | Remote Global Radiation Oncology Education and Training: A Pathway to Increase Access to High-Quality Radiation Therapy Services in Low- and Middle-Income Countries. | Adv Radiat Oncol | 2023 |
| 36874706 | The Association of Radiation Dose With Overall Survival for Patients Treated With Prostate Stereotactic Body Radiation Therapy. | Cureus | 2023 |
| 36579470 | Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126. | Cancer | 2023 |
| 36776318 | Quality improvements in radiation oncology clinical trials. | Front Oncol | 2023 |
| 36736921 | Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG Oncology RTOG 0415. | Int J Radiat Oncol Biol Phys | 2023 |
| 36637862 | Logistical, technical, and radiation safety aspects of establishing a radiopharmaceutical therapy program: A case in Lutetium-177 prostate-specific membrane antigen (PSMA) therapy. | J Appl Clin Med Phys | 2023 |
| 34016556 | Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical Prostatectomy. | Eur Urol Oncol | 2022 |
| 35675855 | The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521. | Int J Radiat Oncol Biol Phys | 2022 |
| 35641370 | Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapy. | Brachytherapy | 2022 |
| 35469702 | High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium. | Eur Urol | 2022 |
| 35569466 | The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial. | Lancet | 2022 |
| 35717045 | Lutetium-177 DOTATATE: A Practical Review. | Pract Radiat Oncol | 2022 |
| 35717043 | Lutetium-177 Prostate-Specific Membrane Antigen Therapy: A Practical Review. | Pract Radiat Oncol | 2022 |
| 35776901 | Methodological Comparison of Mapping the Expanded Prostate Cancer Index Composite to EuroQoL-5D-3L Using Cross-Sectional and Longitudinal Data: Secondary Analysis of NRG/RTOG 0415. | JCO Clin Cancer Inform | 2022 |
| 36483060 | An Analysis of Major Target Deviations in Craniospinal Irradiation Treatment Plans for Patients With Intermediate-Risk Medulloblastoma Within a Phase 3 Clinical Trial (Children's Oncology Group Study ACNS0331). | Adv Radiat Oncol | 2022 |
| 35934601 | Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN). | Eur Urol | 2022 |
| 35963472 | ASTRO Supports Access to Evidence-Based Cancer Care for All Patients, Regardless of Pregnancy Status, and Protection for Physicians Recommending and Providing Evidence-Based Care. | Int J Radiat Oncol Biol Phys | 2022 |
| 35015566 | Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials Network Cooperative Groups. | J Clin Oncol | 2022 |
| 34919884 | Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126. | Int J Radiat Oncol Biol Phys | 2022 |
| 35249864 | Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic Chemotherapy. | Eur Urol Oncol | 2022 |
| 35282697 | Reply by Authors. | J Urol | 2022 |
| 35123889 | Assessing the role of external beam radiation therapy in combination with brachytherapy versus brachytherapy alone for unfavorable intermediate-risk prostate cancer. | Brachytherapy | 2022 |
| 35243392 | Treatment Patterns and Overall Survival Outcomes Among Patients Aged 80 yr or Older with High-risk Prostate Cancer. | Eur Urol Open Sci | 2022 |
| 35086762 | Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate Cancer. | Clin Genitourin Cancer | 2022 |
| 35085038 | Survival Outcomes in Men with Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Treated with Prostate-Only versus Whole Pelvic Radiation Therapy. | J Urol | 2022 |
| 35193114 | Outcomes of Patients With Unfavorable Intermediate-Risk Prostate Cancer Treated With External-Beam Radiotherapy Versus Brachytherapy Alone. | J Natl Compr Canc Netw | 2022 |
| 34464743 | Implementation of Magnetic Resonance Safety Program for Radiation Oncology. | Pract Radiat Oncol | 2022 |
| 34695615 | Feasibility of Same-Day Prostate Fiducial Markers, Perirectal Hydrogel Spacer Placement, and Computed Tomography and Magnetic Resonance Imaging Simulation for External Beam Radiation Therapy for Low-Risk and Intermediate-Risk Prostate Cancer. | Pract Radiat Oncol | 2022 |
| 34481017 | Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial. | Int J Radiat Oncol Biol Phys | 2022 |
| 34740768 | Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526). | Int J Radiat Oncol Biol Phys | 2022 |
| 32861817 | NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2021 |
| 33852571 | Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415. | PLoS One | 2021 |
| 33741471 | Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistency. | Radiother Oncol | 2021 |
| 33837069 | Improved Radium-223 Therapy with Combination Epithelial Sodium Channel Blockade. | J Nucl Med | 2021 |
| 33604458 | Concurrent paclitaxel and radiation therapy for the treatment of cutaneous angiosarcoma. | Clin Transl Radiat Oncol | 2021 |